Skip to main content
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
54.25
+0.70 (1.31%)
At close: Jun 6, 2025, 4:00 PM
54.49
+0.24 (0.44%)
After-hours: Jun 6, 2025, 7:48 PM EDT

Halozyme Therapeutics Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Royalties
618.59M 570.99M 522.62M 482.00M 468.82M 447.87M 431.79M 416.91M
Royalties Growth
31.95% 27.49% 21.04% 15.61% 20.05% 24.24% 36.16% 50.98%
Product Sales
322.95M 303.49M 303.73M 303.64M 298.64M 300.85M 282.42M 257.27M
Product Sales Growth
8.14% 0.88% 7.55% 18.02% 30.02% 57.49% 79.98% 113.44%
Revenues Under Collaborative Agreements
142.77M 140.84M 121.00M 87.67M 95.53M 80.53M 66.50M 99.47M
Revenues Under Collaborative Agreements Growth
49.45% 74.88% 81.95% -11.86% 12.67% -25.85% -37.60% 9.55%

Operating Expense Breakdown
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Cost of Sales
179.49M 159.42M 169.66M 175.06M 185.52M 192.36M 182.18M 174.68M
Cost of Sales Growth
-3.25% -17.13% -6.87% 0.22% 17.01% 38.09% 53.39% 94.00%
Selling, General, and Administrative
161.56M 154.34M 149.69M 143.72M 146.96M 149.18M 149.32M 148.52M
Selling, General, and Administrative Growth
9.94% 3.45% 0.25% -3.23% -12.03% 3.94% 24.90% 51.16%
Research and Development
74.74M 79.05M 79.94M 78.81M 77.50M 76.36M 77.59M 76.98M
Research and Development Growth
-3.56% 3.52% 3.03% 2.38% 6.55% 14.65% 43.30% 67.60%
Amortization
71.05M 71.05M 71.05M 73.63M 73.70M 73.77M 60.56M 67.42M
Amortization Growth
-3.60% -3.69% 17.31% 9.22% 20.85% 70.98% 56.92% 491.20%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.